Cytoreg

N/A

Report date: 2025/03/18 18:14:38
NME

Base Information

Drug NameCytoreg
Drug Alias Nameanticancer therapy (Cytorex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth factor receptors antagonists
TargetsGrowth factor receptors
Therapy Area/IndicationsIschemic StrokeNerve DegenerationImmune System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytorex Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytorex Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationImmune System DiseasesNeoplasms
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A